Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform
Jotup,
This trial is being conducted in collaboration with Oregon Health
This trial is being conducted in collaboration with Oregon Health
SAN FRANCISCO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company…
SAN FRANCISCO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company…
■ Hugh Harris, postdoctoral researcher in microbiology and bioinformatics, University College Cork EVERY day, in countries all…